CHP Merger Corp.
Status: Liquidated
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $300.00M |
|---|---|
| IPO Date | Nov 22, 2019 |
| CEO | James T. Olsen |
| Left Lead | JP Morgan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare in the United States |
| IPO Geography | US/Canada |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 24, 2021 |
| Closing Date | Apr 26, 2022 |
CHPM
CHPMU
CHPMW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on CHP Merger Corp.:
- Structure and cap table
- 6 directors & officers
- 21 filings and events
- 3 underwriters
- 3 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Joseph R. Swedish | 68 | Chairman |
| James T. Olsen | 48 | CEO & Director |
| Benson Jose | 40 | CFO |
| James A. Deal | 69 | Director |
| Ken Goulet | 60 | Director |
| Jack Krouskup | 70 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| JP Morgan | Joint BR | 9,166,667 | units |
| Credit Suisse | Joint BR | 9,166,667 | |
| Morgan Stanley | Joint BR | 9,166,666 | |
| 27,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.